Skip to main content
Log in

Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy

  • Full Papers
  • Published:
Journal of Neural Transmission / General Section JNT Aims and scope Submit manuscript

Summary

The administration of the 5-HT1A agonist 8-OH-DPAT, 0.1 mg kg−1 sc −20 min, produced a moderate suppression of conditioned avoidance behavior (60% of controls) in the rat. This effect, however, was not seen after administration of higher doses, 0.4 and 1.6 mg kg−1 sc. The number of intertriai crosses were not affected by the lower dose but significantly increased by administration of the two higher doses of 8-OH-DPAT. The dopamine D2 receptor blocking agent raclopride, 0.05 mg kg−1, by itself did not suppress the avoidance behavior, but in combination with 8-OH-DPAT produced suppression of avoidance behavior (30% of controls) as well as intertrial crosses. Open field locomotor activity was suppressed by raclopride, 0.1 mg kg−1 sc, or by 8-OH-DPAT, 0.1 mg kg−1 sc. The combined treatment produced a further suppression of locomotor activity and a marked increase in “immobility” (stationary movements). Treadmill locomotion, however, was not affected by either compound by itself, whereas the combined treatment impaired treadmill performance. Suppression of treadmill performance by a higher dose of raclopride, 0.4 mg kg−1 sc, was not altered by the additional treatment with 8-OH-DPAT, 0.1 mg kg−1. In contrast to the additive effects of 8-OH-DPAT and raclopride on conditioned avoidance behavior, open field locomotion and treadmill performance, the catalepsy produced by raclopride, 16 mg kg−1 was completely antagonised by treatment with 8-OH-DPAT 0.1 mg kg−1. Taken together, the present findings demonstrate strong interactions between a 5-HT agonist and a DA D2 antagonist on some critical tests for antipsychotic-like actions and extrapyramidal motor effects in rats, and suggest new possibilities in the search for new antipsychotic drugs with higher clinical efficacy and less extrapyramidal side effects

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ahlenius S, Archer T, Tandberg B, Hillegaart V (1984) Effects of (−)3-PPP on aquisition and retention of a conditioned avoidance response in the rat. Psychopharmacology 84: 441–445

    Google Scholar 

  • Ahlenius S, Larsson K (1985) Antagonism by lisuride and 8-OH-DPAT of 5-HTP-induced prolongation of the performance of male rat sexual behavior. Eur J Pharmacol 110: 379–381

    Google Scholar 

  • Ahlenius S, Hillegaart V (1986) Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effects produced by pre- and postsynaptic inhibition of dopaminergic neurotransmission. Pharmacol Biochem Behav 24: 1409–1415

    Google Scholar 

  • Ahlenius S, Hillegaart V, Wijkström A (1989) Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat. Naunyn Schmiedebergs Arch Pharmacol 339: 551–556

    Google Scholar 

  • Andén N-E, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U (1970) Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 11: 303–314

    Google Scholar 

  • Balsara JJ, Jadhav JH, Chandorka AG (1979) Effects of drugs influencing central serotonergic mechanisms of haloperidol-induced catalepsy. Psychopharmacology 62: 67–69

    Google Scholar 

  • Broekkamp RW, Cervo SK, Berendsen HHG, van Delft AML (1988) Effect of metergoline, fenfluramine and 8-OH-DPAT on catalepsy induced by haloperidol or morphine. Naunyn Schmiedebergs Arch Pharmacol 338: 191–195

    Google Scholar 

  • Carlsson M, Eriksson E (1986) A central serotonin receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, has different effects on prolactin secretion in male and female rats. Pharmacol Toxicol 58: 297–302

    Google Scholar 

  • Clark D, Carlsson A, Hjorth S, Engel J, Lindberg P (1983) The effect of the enantiomers of 3-PPP on conditioned avoidance responding in the rat. Psychopharmacology 81: 14–17

    Google Scholar 

  • Creese I (1987) Biochemical properties of CNS dopamine receptors. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 257–264

    Google Scholar 

  • Engel JA, Hjorth S, Svensson K, Carlsson A, Liljequist S (1984) Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur J Pharmacol 105: 365–368

    Google Scholar 

  • Fuenmayor LD, Vogt M (1979) The influence of cerebral 5-hydroxytryptamine on catalepsy induced by brain-amine depleting neuroleptics or by cholinomimetics. Br J Pharmacol 67: 309–318

    Google Scholar 

  • Gumulka W, Kostowski W, Czlonkowski A (1973) Role of 5-HT in the action of some drugs affecting extrapyramidal system. Pharmacology 10: 363–372

    Google Scholar 

  • Hillegaart V, Ahlenius S (1987) Effects of raclopride on exploratory locomotor activity, treadmill locomotion, conditioned avoidance behavior and catalepsy in rats: behavioral profile comparisons between raclopride, haloperidol and preclamol. Pharmacol Toxicol 60: 350–354

    Google Scholar 

  • Hillegaart V, Wadenberg M-L, Ahlenius S (1989) Effects of 8-OH-DPAT on motor activity in the rat. Pharmacol Biochem Behav 32: 797–800

    Google Scholar 

  • Hillegaart V, Hjorth S, Ahlenius S (1989) Regional forebrain 5-HT synthesis after local application of 5-HT or 8-OH-DPAT into the dorsal (DR) or median (MR) raphe nucleus of the rat. Eur J Neurosci S2: 196

    Google Scholar 

  • Hillegaart V, Hjorth S, Ahlenius S (1990) Effects of 5-HT and 8-OH-DPAT on forebrain monoamine synthesis after local application into the median and dorsal raphe nuclei of the rat. J Neural Transm [GenSect] 81: 131–145

    Google Scholar 

  • Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikström H, Arvidsson L-E, Hacksell U, Nilsson JLG (1982) 8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT receptor stimulating activity. J Neural Transm 55: 169–188

    Google Scholar 

  • Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson L-E, Johansson A, Nilsson JLG (1983) Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP. Psychopharmacology 81: 89–99

    Google Scholar 

  • Hjorth S, Magnusson T (1988) The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn Schmiedebergs Arch Pharmacol 338: 463–471

    Google Scholar 

  • Invernizzi RW, Cervo L, Samanin R (1988) 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis. Neuropharmacology 27: 515–518

    Google Scholar 

  • Kostowski W, Gumulka W, Czlonkowski A (1972) Reduced cataleptogenic effects of some neuroleptics in rats with lesioned midbrain raphe and treated withp-chlorophenylalanine. Brain Res 48: 443–446

    Google Scholar 

  • Köhler C, Hall H, ögren S-O, Gawell L (1985) Specific in vitro and in vivo binding of [3 H]-raclopride. A potent substituted benzamide drug with high affinity for dopamine D2 receptors in the rat brain. Biochem Pharmacol 34: 2251–2259

    Google Scholar 

  • Li CC (1964) Introduction to experimental statistics. Mc Graw-Hill, New York, pp 207–226

    Google Scholar 

  • McMillen BA (1985) Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission. J Neural Transm 64: 1–12

    Google Scholar 

  • McMillen BA, Scott SM, Davanzo EA (1988) Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs. J Pharm Pharmacol 40: 885–887

    Google Scholar 

  • Middlemiss DN, Fozard JR. (1983) 8-hydroxy-2-(di-n-propylamino)tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol 30: 151–153

    Google Scholar 

  • Mittmann SM, Geyer MA (1989) Effects of 5-HT1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens. Psychopharmacology 98: 321–329

    Google Scholar 

  • Palacios JM, Pazos A, Hoyer D (1987) Characterization and mapping of 5-HT1A sites in the brain of animals and man. In: Dourish CT, Ahlenius S, Hutson PH (eds) Brain 5-HT1A receptors. Ellis Horwood, Chichester, pp 67–81

    Google Scholar 

  • Siegel S (1988) Nonparametric statitics for the behavioral sciences. McGraw-Hill, New York

    Google Scholar 

  • Wadenberg M-L, Ahlenius S (1988) Suppression of conditioned avoidance by 8-OH-DPAT in the rat. J Neural Transm 74: 195–198

    Google Scholar 

  • Waldmeier PC, Delini-Stula AA (1979) Serotonin-dopamine interactions in the nigrostriatal system. Eur J Pharmacol 55: 363–373

    Google Scholar 

  • Winer BJ (1971) Statistical principles in experimental design. McGraw-Hill, New York

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wadenberg, M.L., Ahlenius, S. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy. J. Neural Transmission 83, 43–53 (1991). https://doi.org/10.1007/BF01244451

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01244451

Keywords

Navigation